Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950129 · ClinicalTrials.gov registry record · Phase 2
IRB-HSR # 14073 Investigation of Pelvic Girdle Dysfunction in the Low Back Pain Population
A Phase 2 study, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
NCT02950129 is a Phase 2 study that has completed, run by University of Virginia. The registered enrollment target is 55 participants.
The verdict
NCT02950129, a Phase 2 study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
Study Summary
The subjects will undergo a specific physical exam of tests reported to be diagnostic of sacroiliac joint (SIJ) pain prior to receiving the routine injection in the SIJ that which is being performed as part of their normal medical care. Routine care involves use of any number of these tests, but doesn't routinely include assessment of all 6 tests in all patient's treatment. The subject will fill out a Visual Analog Scale for pain and a pain drawing prior to and after the injection. The tests will be repeated after the injection. The investigators propose to investigate a cluster of tests proposed by Laslett as well as compare the results of the ASLR and the Gillet Test both before and after SIJ injection to determine the validity of these tests in a low back patients presenting for injections thought to be from the sacroiliac joint. The secondary purpose would be the development of a clinical predictor rule to determine examination characteristics of patients who may benefit from intraarticular injections of the SIJ.
Interventions
- OTHER SIJ pain diagnostic tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02950129
The ClinicalTrials.gov registry entry for NCT02950129 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SIJ pain diagnostic tests is the first listed.
NCT02950129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02950129 about?
NCT02950129 is a clinical study titled "IRB-HSR # 14073 Investigation of Pelvic Girdle Dysfunction in the Low Back Pain Population". The subjects will undergo a specific physical exam of tests reported to be diagnostic of sacroiliac joint (SIJ) pain prior to receiving the routine injection in the SIJ that which is being performed as part of their normal medical care. Routine care involves use of any number of these tests, but doe...
What is the current status of trial NCT02950129?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2009-02. Estimated completion is 2011-06.
What interventions are being tested in trial NCT02950129?
The interventions under investigation include: SIJ pain diagnostic tests (OTHER).
Who is sponsoring clinical trial NCT02950129?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.